Who are equimolar oxygen-nitrous oxide mixture's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/equimolar-oxygen-nitrous-oxide-mixture.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

equimolar oxygen-nitrous oxide mixture — Competitive Intelligence Brief

equimolar oxygen-nitrous oxide mixture (equimolar oxygen-nitrous oxide mixture) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inhalational anesthetic/analgesic mixture. Area: Anesthesia, Acute Pain Management.

marketed Inhalational anesthetic/analgesic mixture NMDA receptor antagonist (nitrous oxide component) Anesthesia, Acute Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

equimolar oxygen-nitrous oxide mixture (equimolar oxygen-nitrous oxide mixture) — Centre Hospitalier Universitaire de Nīmes. An equimolar mixture of oxygen and nitrous oxide provides analgesia and anxiolysis through nitrous oxide's effects on central nervous system receptors while maintaining adequate oxygenation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
equimolar oxygen-nitrous oxide mixture TARGET	equimolar oxygen-nitrous oxide mixture	Centre Hospitalier Universitaire de Nīmes	marketed	Inhalational anesthetic/analgesic mixture	NMDA receptor antagonist (nitrous oxide component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inhalational anesthetic/analgesic mixture class)

Centre Hospitalier Universitaire de Nīmes · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). equimolar oxygen-nitrous oxide mixture — Competitive Intelligence Brief. https://druglandscape.com/ci/equimolar-oxygen-nitrous-oxide-mixture. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab